| 1. |
Esteller M, Herman JG. (2002) Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours.
J Pathol. 196, 1–7.
|
| |
| 2. |
Feinberg AP. (2007) Phenotypic plasticity and the epigenetics of human disease. Nature
447, 433–440.
|
| |
| 3. |
Ozanne SE, Constancia M. (2007) Mechanisms of disease: the developmental origins of disease and the role of the epigenotype.
Nat Clin Pract Endocrinol Metab. 3, 539–546.
|
| |
| 4. |
Shames DS, Minna JD, Gazdar AF. (2007) DNA methylation in health, disease, and cancer. Curr Mol Med. 7, 85–102.
|
| |
| 5. |
Jones PA, Baylin SB. (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet. 3, 415–428.
|
| |
| 6. |
Feinberg AP, Ohlsson R, Henikoff S. (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet. 7, 21–33.
|
| |
| 7. |
Glasspool RM, Teodoridis JM, Brown R. (2006) Epigenetics as a mechanism driving polygenic clinical drug resistance. Br J Cancer. 94, 1087–1092.
|
| |
| 8. |
Chekhun VF, Lukyanova NY, Kovalchuk O, Tryndyak VP, Pogribny IP. (2007) Epigenetic profiling of multidrug-resistant human
MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets. Mol Cancer Ther. 6, 1089–1098.
|
| |
| 9. |
Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N, Jiang A, Perou CM, Kim YH, Pollack JR, Fong KM, Lam CL, et al.
(2006) A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
PLoS Med. 3, e486.
|
| |
| 10. |
Gryn J, Zeigler ZR, Shadduck RK, Lister J, Raymond JM, Sbeitan I, Srodes C, Meisner D, Evans C. (2002) Treatment of myelodysplastic
syndromes with 5-azacytidine. Leuk Res. 26, 893–897.
|
| |
| 11. |
Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D. (2005) Chromosome-wide and promoter-specific analyses
identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet. 37, 853–862.
|
| |
| 12. |
Wilson IM, Davies JJ, Weber M, Brown CJ, Alvarez CE, MacAulay C, Schubeler D, Lam WL. (2006) Epigenomics: mapping the methylome.
Cell Cycle
5, 155–158.
|
| |
| 13. |
Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL. (1992) A genomic sequencing protocol that
yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A
89, 1827–1831.
|
| |
| 14. |
Gonzalgo ML, Liang G, Spruck CH, 3rd, Zingg JM, Rideout WM, 3rd, Jones PA. (1997) Identification and characterization of differentially
methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res. 57, 594–599.
|
| |
| 15. |
Huang TH, Laux DE, Hamlin BC, Tran P, Tran H, Lubahn DB. (1997) Identification of DNA methylation markers for human breast
carcinomas using the methylation-sensitive restriction fingerprinting technique. Cancer Res. 57, 1030–1034.
|
| |
| 16. |
Livak KJ, Schmittgen TD. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta
Delta C(T)) Method. Methods
25, 402–408.
|
| |
| 17. |
Coe BP, Ylstra B, Carvalho B, Meijer GA, Macaulay C, Lam WL. (2007) Resolving the resolution of array CGH. Genomics
89, 647–653.
|
| |
| 18. |
Khojasteh M, Lam WL, Ward RK, MacAulay C. (2005) A stepwise framework for the normalization of array CGH data. BMC Bioinformatics
6, 274.
|
| |
| 19. |
Branham WS, Melvin CD, Han T, Desai VG, Moland CL, Scully AT, Fuscoe JC. (2007) Elimination of laboratory ozone leads to a
dramatic improvement in the reproducibility of microarray gene expression measurements. BMC Biotechnol. 7, 8.
|
| |
| 20. |
Chi B, DeLeeuw RJ, Coe BP, MacAulay C, Lam WL. (2004) SeeGH – a software tool for visualization of whole genome array comparative
genomic hybridization data. BMC Bioinformatics. 5, 13.
|
| |
| 21. |
Chari R, Lockwood WW, Coe BP, Chu A, Macey D, Thomson A, Davies JJ, MacAulay C, Lam WL. (2006) SIGMA: a system for integrative
genomic microarray analysis of cancer genomes. BMC Genomics
7, 324.
|
| |